Organon & Co (NYSE:OGN) is a healthcare company focused on improving the lives of women worldwide. This organization operates globally, channeling its efforts into developing and bringing to market a broad range of therapies and solutions specifically tailored to address a variety of women's health issues. Beyond its primary mission, Organon is also engaged in expanding its portfolio to include biosimilars, with a keen interest in respiratory, cardiovascular, and dermatological treatments among others. The company is committed to innovation, aiming to fill significant gaps in global healthcare through strategic partnerships, rigorous research, and product development.